NOVEL PROSTATE-SPECIFIC OR TESTIS-SPECIFIC NUCLEIC ACID MOLECULES, POLYPEPTIDES, AND DIAGNOSTIC AND THERAPEUTIC METHODS - Patent 1268526

(19)

(11)

EP 1 268 526 A2

(12)

(88)	Date of publication A3:
	17.01.2002

(43)	Date of publication:
	02.01.2003 Bulletin 2003/01

(21)	Application number: 01922630.7

(22)	Date of filing: 23.03.2001

(51)	International Patent Classification (IPC)⁷: C07K 14/00, G01N 33/53, A61K 38/00

(86)	International application number:
	PCT/US0109/410

(87)	International publication number:
	WO 0107/2962 (04.10.2001 Gazette 2001/40)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

24.03.2000 US 191929 P

(71)	Applicant: Saatcioglu, Fahri
	Wellesley, MA 02482 (US)

(72)	Inventor:
	Saatcioglu, Fahri Wellesley, MA 02482 (US)

(74)	Representative: Bösl, Raphael, Dr. rer. nat., Dipl.-Chem.
	Patent- und RechtsanwälteBardehle . Pagenberg . Dost . Altenburg . Geissler . IsenbruckGalileiplatz 1 81679 München 81679 München (DE)

(54)	NOVEL PROSTATE-SPECIFIC OR TESTIS-SPECIFIC NUCLEIC ACID MOLECULES, POLYPEPTIDES, AND DIAGNOSTIC AND THERAPEUTIC METHODS